Aesica is a leading global contract manufacturer of pharmaceutical products.

Investment type
  • Management buyout
Exit type
  • Private equity sale
Exit date

September 2011

The Team
LDC Team
Quote mark

LDC has proved itself a high effective partner, providing the capital, expertise and support Aesica needed to create significant and sustainable growth and leave us with a strong platform from which to drive further success.”

Dr. Robert Hardy
CEO, Aesica